The vaccines are also easier to make and multivalent shots can be formulated in prefilled syringes, said Vicebio chief executive Emmanuel Hanon, who was formerly GSK's vaccine chief. New Cambridge ...

GSK plc's stock price has significantly outperformed the healthcare sector this year, supported by its healthy Q1 2025 ...

GSK will use AI, dual sourcing to offset tariff hit Q1 results better-than-expected Shares up 3.8% Maintains 2025 turnover and profit forecasts April 30 (Reuters) - GSK (GSK.L), opens new tab on ...

GSK (GSK) stock gains as the company's Q1 2025 results beat Street forecasts thanks to its Specialty Medicines business. Read ...

GSK’s dealmaking will be “cautious and disciplined” under the current trade war, but the pharma will focus on looking for ...

BNP Paribas Exane analyst Peter Verdult initiated coverage of GSK (GSK) with a Neutral rating and $35.25 price target Discover outperforming stocks and invest smarter with Top Smart Score Stocks.

In a report released today, Jo Walton from UBS maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of p1,600.00. The company’s shares opened today at p1 ...

Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as ...

GSK Plc reported better-than-expected profit in the first quarter as sales from its asthma and HIV drugs offset a lackluster vaccine performance. The UK drugmaker’s shares surged after it ...

April 15 (Reuters) - British pharmaceutical giant GSK (GSK.L), opens new tab has not met required ethical and regulatory standards in the marketing and prescription information for its Omjjara ...

GSK has been found guilty of bringing discredit on the pharma industry after a complainant flagged “a shocking error” in the prescribing information for the JAK inhibitor Omjjara. A person who ...